DK0424350T3 - Derivater af 1,4-dideoxy-1,4-imino-D-mannitol - Google Patents
Derivater af 1,4-dideoxy-1,4-imino-D-mannitolInfo
- Publication number
- DK0424350T3 DK0424350T3 DK90870187.3T DK90870187T DK0424350T3 DK 0424350 T3 DK0424350 T3 DK 0424350T3 DK 90870187 T DK90870187 T DK 90870187T DK 0424350 T3 DK0424350 T3 DK 0424350T3
- Authority
- DK
- Denmark
- Prior art keywords
- imino
- mannitol
- dideoxy
- derivatives
- novel derivatives
- Prior art date
Links
- RVNSAAIWCWTCTJ-KVTDHHQDSA-N (2r,3s,4r)-2-[(1s)-1,2-dihydroxyethyl]pyrrolidine-3,4-diol Chemical class OC[C@@H](O)[C@H]1NC[C@@H](O)[C@H]1O RVNSAAIWCWTCTJ-KVTDHHQDSA-N 0.000 title abstract 2
- NNJNGAUYDRUWSP-JKUQZMGJSA-N (2s,3r)-2-[(2s)-3-fluoro-2-hydroxypropyl]azetidine-2,3-diol Chemical compound FC[C@@H](O)C[C@@]1(O)NC[C@H]1O NNJNGAUYDRUWSP-JKUQZMGJSA-N 0.000 abstract 1
- 102000001696 Mannosidases Human genes 0.000 abstract 1
- 108010054377 Mannosidases Proteins 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 125000002827 triflate group Chemical class FC(S(=O)(=O)O*)(F)F 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/424,628 US5023340A (en) | 1989-10-20 | 1989-10-20 | Pyrrolizioines and synthesis thereof |
| US07/461,859 US4996329A (en) | 1989-10-20 | 1990-01-08 | Derivatives of 1,4-dideoxy-1,4-imino-D-mannitol and a process for their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0424350T3 true DK0424350T3 (da) | 1995-04-10 |
Family
ID=27026400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90870187.3T DK0424350T3 (da) | 1989-10-20 | 1990-10-15 | Derivater af 1,4-dideoxy-1,4-imino-D-mannitol |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4996329A (da) |
| EP (1) | EP0424350B1 (da) |
| JP (1) | JP2975665B2 (da) |
| AT (1) | ATE117992T1 (da) |
| CA (1) | CA2028048C (da) |
| DE (1) | DE69016571T2 (da) |
| DK (1) | DK0424350T3 (da) |
| ES (1) | ES2069060T3 (da) |
| GR (1) | GR3015238T3 (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5100797A (en) * | 1989-06-27 | 1992-03-31 | Monsanto Company | Fucosidase inhibitors |
| US5773239A (en) * | 1993-10-19 | 1998-06-30 | Mount Sinai Hospital Corporation. | Mannosidase inhibitors, process for their preparation and their use as therapeutic agents |
| US5650413A (en) * | 1995-06-07 | 1997-07-22 | Glycodesign Inc. | Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents |
| US6048870A (en) * | 1996-10-01 | 2000-04-11 | Glycodesign | 3, 5, and/or 6 substituted analogues of swainsonine processes for their preparation and their use as therapeutic agents |
| US5952363A (en) * | 1997-03-04 | 1999-09-14 | Novo Nordisk A/S | Pyrrolidine compounds useful in the treatment of diabetes |
| ZA981920B (en) * | 1997-03-07 | 1998-09-07 | Novo Nordisk As | Novel heterocyclic compounds |
| CA2286766A1 (en) | 1997-04-15 | 1998-10-22 | Glycodesign Inc. | Alkaloid halide salts of swainsonine and methods of use |
| WO1999021858A1 (en) * | 1997-10-24 | 1999-05-06 | Glycodesign Inc. | Synthesis of swainsonine salts |
| ES2302697T3 (es) | 1999-08-10 | 2008-08-01 | The Chancellor, Masters And Scholars Of The University Of Oxford | Compuestos n-alquilicos de cadena larga y derivados oxa de los mismos y uso como composiciones antivirales. |
| US7256005B2 (en) | 1999-08-10 | 2007-08-14 | The Chancellor, Masters And Scholars Of The University Of Oxford | Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity |
| US20080138351A1 (en) * | 2006-08-02 | 2008-06-12 | United Therapeutics Corporation | Liposome treatment of viral infections |
| JP2010510171A (ja) * | 2006-08-21 | 2010-04-02 | ユナイテッド セラピューティクス コーポレーション | ウイルス感染症の治療のための併用療法 |
| US20090252785A1 (en) * | 2008-03-26 | 2009-10-08 | University Of Oxford | Endoplasmic reticulum targeting liposomes |
| CN102427804A (zh) * | 2009-03-27 | 2012-04-25 | 牛津大学之校长及学者 | 降低胆固醇水平的脂质体 |
-
1990
- 1990-01-08 US US07/461,859 patent/US4996329A/en not_active Expired - Lifetime
- 1990-10-15 ES ES90870187T patent/ES2069060T3/es not_active Expired - Lifetime
- 1990-10-15 DE DE69016571T patent/DE69016571T2/de not_active Expired - Fee Related
- 1990-10-15 AT AT90870187T patent/ATE117992T1/de not_active IP Right Cessation
- 1990-10-15 EP EP90870187A patent/EP0424350B1/en not_active Expired - Lifetime
- 1990-10-15 DK DK90870187.3T patent/DK0424350T3/da active
- 1990-10-19 JP JP2281740A patent/JP2975665B2/ja not_active Expired - Fee Related
- 1990-10-19 CA CA002028048A patent/CA2028048C/en not_active Expired - Fee Related
-
1995
- 1995-03-01 GR GR950400448T patent/GR3015238T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2069060T3 (es) | 1995-05-01 |
| JP2975665B2 (ja) | 1999-11-10 |
| CA2028048C (en) | 2001-06-19 |
| GR3015238T3 (en) | 1995-06-30 |
| DE69016571T2 (de) | 1995-09-07 |
| DE69016571D1 (de) | 1995-03-16 |
| EP0424350A1 (en) | 1991-04-24 |
| JPH03151359A (ja) | 1991-06-27 |
| CA2028048A1 (en) | 1991-04-21 |
| ATE117992T1 (de) | 1995-02-15 |
| EP0424350B1 (en) | 1995-02-01 |
| US4996329A (en) | 1991-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO881697D0 (no) | Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene. | |
| DE3864608D1 (de) | Hmg-coa-reduktasehemmer. | |
| IT8122675A0 (it) | Mercaptoacil derivati di varie proline 4 sostituite e relative composizioni utili per il trattamento dell'ipertensione. | |
| NO892926D0 (no) | Fremgangsmaate for syntese av sukrosederivater. | |
| DE3850676D1 (de) | Hypotensive okulare Mittel. | |
| FI905535A0 (fi) | Foerfarande foer reproduktion av barrtraed genom somatisk embryogenes. | |
| PT923554E (pt) | N-benzilpiperidina e derivados tetrahidropiridina | |
| DE69016571D1 (de) | 1,4-Dideoxy-1,4-imino-D-mannitol-Derivate. | |
| FI904734A0 (fi) | Anordning foer maetning av tryckdifferens. | |
| FI904735A0 (fi) | Anordning foer maetning av tryckdifferens. | |
| NO944406L (no) | Nye 7 e inhibitorer | |
| NO900742D0 (no) | Sammenstilling av verktoeydeler. | |
| NO902750D0 (no) | Fremgangsmaate til fremstilling av 3,5,6-substituerte derivater av 1,2-0-isopropyliden-alfa-glukofuranose og mellomprodukter for fremstilling av derivatene. | |
| NO904210L (no) | Syntese av hydrokarbylaminer. | |
| DK0523829T3 (da) | Fremgangsmåde til syntese af betazeolit | |
| DE68917024D1 (de) | 4(1H)-Chinolonderivate. | |
| MX9205003A (es) | Derivados novedosos de benzopirano. | |
| NO944075L (no) | Fremgangsmåte for fremstilling av (S)-3-amino-1-substituert pyrrolidiner | |
| DK0406211T3 (da) | Fucosidase-inhibitorer | |
| ATE80157T1 (de) | Antiarthritische beta-cycloalkyl-betaoxopropionitrile. | |
| LV11463A (lv) | Aizvietotu 4,6-diamino-5-cianpirimidinu iegusanas panemiens | |
| DE69031965D1 (de) | System zum Durchgang von Hilfsmittelinformation | |
| DK153592A (da) | Fremgangsmåde til fremstilling af 2,3,5,6-tetrachlorpyridin | |
| ES2073495T3 (es) | Benzotiazepinas. | |
| FI982486A7 (fi) | Välituotteet bis-atsa-bisyklisille ahdistusta lievittäville aineille |